Alzheimer's Disease : (Record no. 4591)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 05944nam a22004813i 4500 |
001 - CONTROL NUMBER | |
control field | EBC5496119 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MiAaPQ |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240724113323.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240724s2018 xx o ||||0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781614998761 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9781614998754 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC5496119 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL5496119 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)1050738399 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC523 .A494 2018 |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.831 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Perry, G. |
245 10 - TITLE STATEMENT | |
Title | Alzheimer's Disease : |
Remainder of title | New Beginnings. |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Amsterdam : |
Name of producer, publisher, distributor, manufacturer | IOS Press, Incorporated, |
Date of production, publication, distribution, manufacture, or copyright notice | 2018. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | ©2018. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (682 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
490 1# - SERIES STATEMENT | |
Series statement | Advances in Alzheimer's Disease Series ; |
Volume/sequential designation | v.6 |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Intro -- Title Page -- Preface -- Contents -- Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future -- Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment -- Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies -- The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View -- Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology -- Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease -- Dementia Research: Populations, Progress, Problems, and Predictions -- Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers -- Religious Orders Study and Rush Memory and Aging Project -- Prevention Matters: Time for Global Action and Effective Implementation -- Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle -- Preclinical Alzheimer's Disease: Implications for Refinement of the Concept -- Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review -- The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease -- From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease -- Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment -- A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations -- Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease -- Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation -- Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET -- Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy -- Conquering Alzheimer's Disease by Self Treatment -- Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease -- Iron and Alzheimer's Disease: An Update on Emerging Mechanisms -- Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy? -- Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches -- Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions -- Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease -- Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases -- Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase -- Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation -- Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease -- Our Tau Tales from Normal to Pathological Behavior -- Amyloid-Beta and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies -- New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy -- Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation -- The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning? -- Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | The Amyloid-Beta Oligomer Hypothesis: Beginning of the Third Decade -- Role of Amyloid-Beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade -- Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease -- Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration -- Amyloid-Beta/Drug Interactions from Computer Simulations and Cell-Based Assays. |
588 ## - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on publisher supplied metadata and other sources. |
590 ## - LOCAL NOTE (RLIN) | |
Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alzheimer's disease. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Avila, J. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moreira, P. I. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Perry, G. |
Title | Alzheimer's Disease: New Beginnings |
Place, publisher, and date of publication | Amsterdam : IOS Press, Incorporated,c2018 |
International Standard Book Number | 9781614998754 |
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Advances in Alzheimer's Disease Series |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5496119">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5496119</a> |
Public note | Click to View |
No items available.